ABC - antibiotics-based combinations for the treatment of severe malaria?

Trends in Parasitology

Volumn 25, Issue 12, 2009, Pages 540-544

  Noedl, Harald ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTESUNATE; AZITHROMYCIN; CHLOROQUINE; CLINDAMYCIN; DIHYDROARTEMISININ; DOXYCYCLINE; QUININE; TETRACYCLINE; TIGECYCLINE;

ACUTE KIDNEY FAILURE; ANEMIA; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BRAIN MALARIA; CAUSE OF DEATH; CHILDHOOD MORTALITY; COMBINATION CHEMOTHERAPY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DISEASE SEVERITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENTIATION; DRUG SAFETY; DRUG TREATMENT FAILURE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; LUNG EDEMA; MALARIA CONTROL; MALARIA FALCIPARUM; MENINGITIS; MIXED INFECTION; MONOTHERAPY; MORTALITY; MULTIDRUG RESISTANCE; OUTPATIENT CARE; PARASITE TRANSMISSION; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; PNEUMONIA; PREGNANCY; PREVALENCE; SALMONELLA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA; TROPICS;

ANTI-BACTERIAL AGENTS; ANTIMALARIALS; AZITHROMYCIN; BACTERIAL INFECTIONS; CHILD, PRESCHOOL; CLINDAMYCIN; DOXYCYCLINE; DRUG COMBINATIONS; HUMANS; INFANT; MALARIA, FALCIPARUM; TROPICAL CLIMATE;

BACTERIA (MICROORGANISMS);

EID: 70449106971     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2009.09.001     Document Type: Article

References (51)

1. World Health Organisation (2008) World Malaria Report 2008. WHO/HTM/GMP/2008.1 (http://apps.who.int/malaria/wmr2008/malaria2008.pdf)
2. World Health Organisation (2006) WHO guidelines for the treatment of malaria. WHO/HTM/MAL/2006.1108 (http://apps.who.int/malaria/docs/TreatmentGuidelines2006.pdf)
3. Dondorp A., et al. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366 (2005) 717-725
4. Dondorp A.M., and Day N.P. The treatment of severe malaria. Trans. R. Soc. Trop. Med. 101 (2007) 633-634
5. Bloland P.B., et al. Combination therapy for malaria in Africa: hype or hope?. Bull. WHO 78 (2000) 1378-1388
6. Noedl H., et al. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 359 (2008) 2619-2620
7. Noedl H., et al. Artemisinin-resistant malaria in Asia. N. Engl. J. Med. 361 (2009) 540-541
8. Noedl H. Artemisinin resistance: how can we find it?. Trends Parasitol. 21 (2005) 404-405
9. White N.J., et al. Averting a malaria disaster. Lancet 353 (1999) 1965-1967
10. International Artemisinin Study Group. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363 (2004) 9-17
11. Carrara, V.I. et al. (2009) Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One 4, e4551 DOI:10.1371/journal.pone.0004551 (www.plosone.org)
12. Rogers W.O., et al. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar. J. 8 (2009) 10
13. Peters W. The prevention of antimalarial drug resistance. Pharmacol. Ther. 47 (1990) 499-508
14. White N.J. Preventing antimalarial drug resistance through combinations. Drug Resist. Updat. 1 (1998) 3-9
15. Amexo M. Malaria misdiagnosis: effects on the poor and vulnerable. Lancet 364 (2004) 1896-1898
16. Petti C.A., et al. Laboratory medicine in Africa: a barrier to effective health care. Clin. Infect. Dis.42 (2006) 377-382
17. Reyburn H., et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. Br. Med. J. 329 (2004) 1212
18. Gosling R.D., et al. Presumptive treatment of fever cases as malaria: help or hindrance for malaria control? Malar. J. 7 (2008) 132
19. Gwer S., et al. Over-diagnosis and co-morbidity of severe malaria in African children: a guide for clinicians. Am. J. Trop. Med. Hyg. 77 (2007) 6-13
20. Berkley J., et al. Cerebral malaria versus bacterial meningitis in children with impaired consciousness. QJM 92 (1999) 151-157
21. Hamer D.H., et al. Improved diagnostic testing and malaria treatment practices in Zambia. JAMA 297 (2007) 2227-2231
22. Källander K. Symptom overlap for malaria and pneumonia--policy implications for home management strategies. Acta Trop. 90 (2004) 211-214
23. O'Dempsey T.J. Overlap in the clinical features of pneumonia and malaria in African children. Trans. R. Soc. Trop. Med. Hyg. 87 (1993) 662-665
24. English M. Clinical overlap between malaria and severe pneumonia in Africa children in hospital. Trans. R. Soc. Trop. Med. Hyg. 90 (1996) 658-662
25. Evans J.A., et al. High mortality of infant bacteraemia clinically indistinguishable from severe malaria. QJM. 97 (2004) 591-597
26. Bronzan R.N., et al. Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome. J. Infect. Dis. 195 (2007) 895-904
27. Enwere G. Bacteraemia in cerebral malaria. Ann. Trop. Paediatr. 18 (1998) 275-278
28. Berkley J., et al. Bacteraemia complicating severe malaria in children. Trans. R. Soc. Trop. Med. Hyg. 93 (1999) 283-286
29. Ayoola O.O. Concurrent bacteraemia and malaria in febrile Nigerian infants. Trop. Doct. 35 (2005) 34-36
30. Berkley J., et al. Bacteremia among children admitted to a rural hospital in Kenya. N. Engl. J. Med. 352 (2005) 39-47
31. Kiratisin P. Bacteraemia due to non-typhoidal Salmonella in Thailand: clinical and microbiological analysis. Trans. R. Soc. Trop. Med. Hyg. 102 (2008) 384-388
32. Graham S.M. Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children. Trans. R. Soc. Trop. Med. Hyg. 94 (2000) 310-314
33. Kankwatira A.M. Non-typhoidal salmonella bacteraemia - an under-recognized feature of AIDS in African adults. Trop. Doct. 34 (2004) 198-200
34. Losert H. Experiences with severe P. falciparum malaria in the intensive care unit. Intensive Care Med. 26 (2000) 195-201
35. Petersen P.E. Malaria chemoprophylaxis: when should we use it and what are the options? Expert Rev. Anti. Infect. Ther. 2 (2004) 119-132
36. Checkley A.M., and Hill D.R. Prevention of malaria in long-term travellers. Trends Parasitol. 23 (2007) 462-465
37. Lalloo D.G., et al. UK malaria treatment guidelines. J. Infect. 54 (2007) 111-121
38. Winstanley P.A. Chemotherapy for Falciparum Malaria: The Armoury, the Problems and the Prospects. Parasitol. Today 16 (2000) 146-153
39. Bunnag D., et al. Quinine-tetracycline for multi-drug resistant falciparum malaria. Southeast Asian J. Trop. Med. Public Health 27 (1996) 15-18
40. Noedl H., et al. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. Clin. Infect. Dis. 43 (2006) 1264-1271
41. Noedl H., et al. In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. Antimicrob. Agents Chemother. 51 (2007) 651-656
42. Miller R.S., et al. Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study. Am. J. Trop. Med. Hyg. 74 (2006) 401-406
43. Lell B., and Kremsner P.G. Clindamycin as an antimalarial drug: review of clinical trials. Antimicrob. Agents Chemother. 46 (2002) 2315-2320
44. Taylor W.R., et al. Chloroquine/doxycycline combination versus chloroquine alone, and doxycycline alone for the treatment of Plasmodium falciparum and Plasmodium vivax malaria in northeastern Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 64 (2001) 223-228
45. Dahl E.L., and Rosenthal P.J. Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast. Antimicrob. Agents Chemother. 51 (2007) 3485-3490
46. Sarkar M., et al. Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth 6 (2006) 18
47. Starzengruber P. et al. (2009) Antimalarial activity of tigecycline, a novel glycylcycline antibiotic. Antimicrob. Agents Chemother. DOI:10.1128/AAC.00312-09 (http://aac.asm.org/)
48. Mulligan J.A., et al. The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania. Trop. Med. Int. Health. 11 (2006) 452-461
49. Ramharter M. In vitro activity and interaction of clindamycin combined with dihydroartemisinin against Plasmodium falciparum. Antimicrob. Agents Chemother. 47 (2003) 3494-3499
50. Pradines B. Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo. J. Clin. Microbiol. 44 (2006) 2404-2408
51. Sponer U. Pharmacodynamic interaction of doxycycline and artemisinin in Plasmodium falciparum. Antimicrob. Agents Chemother. 46 (2002) 262-264